Prescription of FDA to OTC

MA En-fu; XI Rong-gang; WANG Xiao-bo; LI Zhong-liang

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

x Close Forever Close

PDF
Cite
Share

facebook

twitter

google

linkedin

Volume 18 Issue 2

Turn off MathJax

Article Contents

Article Navigation > Journal of Pharmaceutical Practice and Service > 2000 > (2): 115-118

MA En-fu, XI Rong-gang, WANG Xiao-bo, LI Zhong-liang. Prescription of FDA to OTC[J]. Journal of Pharmaceutical Practice and Service, 2000, (2): 115-118.

Citation:

MA En-fu, XI Rong-gang, WANG Xiao-bo, LI Zhong-liang. Prescription of FDA to OTC[J]. Journal of Pharmaceutical Practice and Service, 2000, (2): 115-118.

Prescription of FDA to OTC

Received Date: 1999-09-06

Abstract

OTC drugs have the advantage of curative effect,safety and convience.This review mainly introduces the classification to OTC of FDA,providing with full clinical testimony,advertisement,drug combination,some important legislations and the questions remained about OTC.We should draw lesson from foreing advanced experience so that we can develop our study on OTC much better.
- FDA,
- OTC,
- prescripion
References
Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views(2741) PDF downloads(3040) Cited by()

Proportional views